Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K102176
    Date Cleared
    2010-09-01

    (29 days)

    Product Code
    Regulation Number
    870.1280
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    FLEXCATH STEERABLE SHEATH (12 FRENCH), FLEXCATH STEERABLE SHEATH (10 FRENCH) MODEL 3FC12, 3FC10

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The FlexCath Steerable Sheath is intended for percutaneous catheter introduction into the vasculature and into the chambers of the heart. The Sheath deflection facilitates catheter positioning.

    Device Description

    The FlexCath Steerable Sheath is a deflectable catheter introducer used to facilitate placement of a catheter through the skin into the artery or vein. It is comprised of the following two (2) main sections: the shaft and the handle. A dilator is included with each sheath. This application addresses changes to the 12F FlexCath sheath tip and valve assembly.

    AI/ML Overview

    The FlexCath Steerable Sheath & Dilator (K102176) is intended for percutaneous catheter introduction into the vasculature and chambers of the heart. The sheath's deflection facilitates catheter positioning. The predicate devices are K081049 - FlexCath Steerable Sheath & Dilator, Models 3FC10, 3FC12.

    1. Table of Acceptance Criteria and Reported Device Performance

    TestAcceptance CriteriaReported Device Performance
    Hemostasis valve leak testingPer ISO 11070Met
    Hub-to-shaft tensilePer ISO 11070Met
    Shaft leak testingPer ISO 11070Met
    Detachment force: dilator luer lock from sheath valve capNot specifiedMet
    Removal force: dilator from sheathNot specifiedMet
    Tensile testing of bond joints (valve hub to valve cap, hub body to extension tube, stopcock to extension tube)Not specifiedMet
    Sheath tip robustness (multiple catheter deployments/retractions)Not specifiedMet
    Air aspiration and flushing abilityNot specifiedMet
    Tip strengthNot specifiedMet
    Deflection testingNot specifiedMet
    Sterilization cycle impactIn accordance with AAMI TIR28:2001Met
    Biocompatibility: Physicochemical testingUSP 33Met
    Biocompatibility: Cytotoxicity testingISO 10993-5 (2009)Met
    Biocompatibility: Hemolysis testing (human activated and indirect)ISO 10993-4 (2002 Amd 2006)Met
    Biocompatibility (leveraged from predicate): Kligman Maximization TestISO 10993-10 (2002)Met
    Biocompatibility (leveraged from predicate): Rabbit Pyrogen TestISO 10993-11 (2006)Met
    Biocompatibility (leveraged from predicate): Intracutaneous TestISO 10993-10 (2002)Met
    Biocompatibility (leveraged from predicate): Systemic Injection TestISO 10993-11 (2006)Met
    Biocompatibility (leveraged from predicate): Complement Activation AssayISO 10993-4 (2002)Met
    Biocompatibility (leveraged from predicate): UPTTISO 10993-4 (2002)Met
    Biocompatibility (leveraged from predicate): Thrombogenicity In vivo canineISO 10993-4 (2002)Met

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state specific sample sizes for each test in the test set. However, it mentions "representative finished sterilized samples" were used for in vivo, ex vivo animal testing, biocompatibility, and mechanical testing. The data provenance is primarily through a series of standardized tests (ISO, USP, AAMI TIR). The source of the animal models for in vivo testing is not specified, but the human cells for hemolysis testing and canine for thrombogenicity testing are mentioned. It is implicitly a prospective study since testing was performed on the modified device to demonstrate performance.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    Not applicable. This is a medical device, and the "ground truth" for performance is established through adherence to engineering standards and physical/biological test results, not expert interpretation of data.

    4. Adjudication Method for the Test Set

    Not applicable. This is a medical device, and the "adjudication" is based on meeting predefined technical and biological specifications outlined in the referenced standards.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    No, an MRMC comparative effectiveness study was not done as this is a medical device and not an AI-assisted diagnostic tool.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    Yes, the device performance was evaluated in a standalone manner through various functional, mechanical, and biocompatibility tests. There is no "human-in-the-loop" aspect to these performance assessments, as they measure the intrinsic properties and behavior of the device itself.

    7. The Type of Ground Truth Used

    The ground truth used for this device's acceptance is based on an objective assessment of physical and biological properties against established industry standards and regulatory guidance. This includes:

    • Engineering standards compliance: ISO 11070 for mechanical tests.
    • Biocompatibility standards compliance: ISO 10993 series and USP 33 .
    • Effectiveness of sterilization: AAMI TIR28:2001.

    8. The Sample Size for the Training Set

    Not applicable. This is a physical medical device, not an AI/algorithm-based system requiring a training set.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable. As there is no training set, there is no ground truth established for one.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1